Obesity Featured Articles

  1. Taking A Concierge Approach To Modern Pharma Meetings 12/10/2025

    Pharma meetings run smoother when they reflect real site needs. This article breaks down how travel, timing, venue, and training choices strengthen engagement from the start. 

  2. Year-In-Review: Clinical Research Today And Tomorrow 12/10/2025

    As the industry prepares for 2026, sponsors and investors alike face a pivotal moment — one that demands a more deliberate, insight-driven approach to early clinical development.

  3. MHRA International Recognition: Fast-Track UK Market Access 12/10/2025

    MHRA’s IRP accelerates UK approvals via trusted regulators, but faster authorization only translates to access when aligned with NICE evidence needs, pricing policy, and coordinated launch strategy.

  4. Preserving Genomic Data's Living Legacy 12/10/2025

    Public genomic datasets like TCGA transformed cancer research, guiding assay validation and cohort design. Today, matched biospecimens complete the loop between digital insight and biological confirmation.

  5. ISCTM 2025 Findings To Strengthen Clinical Trial Rigor 12/10/2025

    Explore how these insights can elevate CNS trial design, strengthen data integrity, and inspire more efficient, reliable methods that advance clinical research with greater confidence.

  6. Transforming An Atopic Dermatitis Trial 12/10/2025

    Discover how integrated data monitoring and targeted rater training can bolster consistency, reduce risk, and enhance confidence in clinician-rated dermatology trials across global development programs.

  7. Europe At A Crossroads: Biotech Investment, Regulation, And Partnership In Real Life 12/10/2025

    Position your biotech for Europe’s next phase by aligning strong science, smart clinical strategy, and the right global partners to navigate funding, regulation, and growth.

  8. The Site Perspective: Why Ambient AI Is The Missing Link In Clinical Trial Data Integrity 12/10/2025

    Discover how AI ambient listening has changed the way Mikel Daniels, DPM, MBA, and his team conduct clinical research at WeTreatFeet Podiatry. 

  9. Why HEOR Keeps Arriving Too Late — And How ClinOps Can Fix It 12/9/2025

    Rob Abbott, CEO of ISPOR, breaks down why HEOR timing keeps clashing with ClinOps timelines and offers practical ways to integrate value, evidence, and payer expectations much earlier in development.

  10. 5 Questions That Put Sponsors Back in Control of Bioanalysis Projects 12/9/2025

    Bioanalysis service quality significantly impacts project success. Don't settle for typical CRO claims; demand better technology, pricing transparency, and dedicated partnership.